Take Action: SGO Needs Your Help on Two Important Requests
Download the SGO Grassroots Advocacy Toolkit
Grassroots Talking Points (July 2025)
Stop the Cut to Medicare Work RVUs!
The Centers for Medicare & Medicaid Services (CMS) recently finalized its Calendar Year (CY) 2026 Medicare Physician Fee Schedule (MPFS) final rule. The 2,000-page rule includes a policy to cut the work relative value units (RVUs) and intraservice times for 1,000’s of CPT codes including procedures performed by gynecologic oncologists.
Despite comments from SGO and other specialty societies, CMS will implement this “efficiency adjustment” if Congress does not intervene. The agency believes that gynecologic oncologists and other physicians who perform procedures become more efficient over time as they become more skilled and that these efficiency gains are not reflected in procedures’ values. To address this concern, the CY2026 MPFS puts in place a 2.5% reduction to work RVUs with additional reductions every three years.
SGO needs your help to prevent this reduction in value to the services you deliver! Tell your representatives to stop this “efficiency adjustment” and ensure gynecologic oncologists are compensated adequately!
Your Voice Matters: Urge Congress to Support Gynecologic Cancer Research and Care in FY 2026
Before the government shut down because of a lapse in appropriations, the House and Senate released their Fiscal Year (FY) 2026 Labor, Health and Human Services, Education, and Related Agencies (Labor-HHS) bills. They have not yet negotiated a final agreement. As Congress determines how to reopen the government and makes final FY 2026 funding decisions, now is a critical time to advocacy for gynecologic cancer research and care programs.
Members of Congress need to hear from you! Please take action now by sending a message to your members of Congress urging them to support full and robust appropriations for gynecologic cancer research and care programs in FY 2026.
Support Defense Health Research for Gynecologic Cancers
Before the government shutdown, the House and Senate advanced their Fiscal Year (FY) 2026 Defense appropriations bills with approval by the full House and the Senate Appropriations Committee. Although both bills provided increases for the Congressionally Directed Medical Research Program (CDMRP), neither bill restored funding to the FY 2024 level of $1.5 million. As Congress determines how to reopen the government and makes final FY 2026 funding decisions, now is the time to advocate for the restoration of funding for research that spans basic biology through drug development, diagnostics, and clinical trials, including for gynecologic cancers. This research improves the health of our nation’s armed services, as well as veterans, military families, and the general public.
Act now by contacting your members of Congress! Please help SGO urge Congress to provide robust funding in FY 2026 for the CDMRP, including the Ovarian Cancer Research Program and the Peer Reviewed Cancer Research Program, which funds research on endometrial cancer.
Please take action now to protect high-impact research for gynecologic cancers!
